94 related articles for article (PubMed ID: 21857017)
21. "Smart" Nanoparticles Enhance the Cytoplasmic Delivery of Anti-RhoC Silencing RNA and Inhibit the Migration and Invasion of Aggressive Breast Cancer Cells.
Kaushal N; Durmaz YY; Bao L; Merajver SD; ElSayed ME
Mol Pharm; 2015 Jul; 12(7):2406-17. PubMed ID: 26020100
[TBL] [Abstract][Full Text] [Related]
22. Interleukin 21 and Its Receptor Play a Role in Proliferation, Migration and Invasion of Breast Cancer Cells.
Wang LN; Cui YX; Ruge F; Jiang WG
Cancer Genomics Proteomics; 2015; 12(5):211-21. PubMed ID: 26417024
[TBL] [Abstract][Full Text] [Related]
23. [Overexpression of NDRG1: relationship with proliferative activity and invasiveness of breast cancer cell line and breast cancer metastasis].
Wang Z; Liu Q; Chen Q; Zhu R; Zhu HG
Zhonghua Bing Li Xue Za Zhi; 2006 Jun; 35(6):333-8. PubMed ID: 16834906
[TBL] [Abstract][Full Text] [Related]
24. Effects of dehydroepiandrosterone on proliferation, migration, and death of breast cancer cells.
López-Marure R; Contreras PG; Dillon JS
Eur J Pharmacol; 2011 Jun; 660(2-3):268-74. PubMed ID: 21497598
[TBL] [Abstract][Full Text] [Related]
25. Insulin like growth factor binding protein-7 reduces growth of human breast cancer cells and xenografted tumors.
Amemiya Y; Yang W; Benatar T; Nofech-Mozes S; Yee A; Kahn H; Holloway C; Seth A
Breast Cancer Res Treat; 2011 Apr; 126(2):373-84. PubMed ID: 20464481
[TBL] [Abstract][Full Text] [Related]
26. Tumor inhibitory effect of gefitinib (ZD1839, Iressa) and taxane combination therapy in EGFR-overexpressing breast cancer cell lines (MCF7/ADR, MDA-MB-231).
Takabatake D; Fujita T; Shien T; Kawasaki K; Taira N; Yoshitomi S; Takahashi H; Ishibe Y; Ogasawara Y; Doihara H
Int J Cancer; 2007 Jan; 120(1):181-8. PubMed ID: 17036319
[TBL] [Abstract][Full Text] [Related]
27. Inhibition of cyclooxygenase-2 decreases breast cancer cell motility, invasion and matrix metalloproteinase expression.
Larkins TL; Nowell M; Singh S; Sanford GL
BMC Cancer; 2006 Jul; 6():181. PubMed ID: 16831226
[TBL] [Abstract][Full Text] [Related]
28. Enhancement of the migration of metastatic human breast cancer cells by phosphatidic acid.
Sliva D; Mason R; Xiao H; English D
Biochem Biophys Res Commun; 2000 Feb; 268(2):471-9. PubMed ID: 10679229
[TBL] [Abstract][Full Text] [Related]
29. Reprimo as a modulator of cell migration and invasion in the MDA-MB-231 breast cancer cell line.
Buchegger K; Ili C; Riquelme I; Letelier P; Corvalán AH; Brebi P; Huang TH; Roa JC
Biol Res; 2016 Jan; 49():5. PubMed ID: 26796959
[TBL] [Abstract][Full Text] [Related]
30. Xenon decreases cell migration and secretion of a pro-angiogenesis factor in breast adenocarcinoma cells: comparison with sevoflurane.
Ash SA; Valchev GI; Looney M; Ni Mhathuna A; Crowley PD; Gallagher HC; Buggy DJ
Br J Anaesth; 2014 Jul; 113 Suppl 1():i14-21. PubMed ID: 25001620
[TBL] [Abstract][Full Text] [Related]
31. Silencing of transforming growth factor-beta1 in situ by RNA interference for breast cancer: implications for proliferation and migration in vitro and metastasis in vivo.
Moore LD; Isayeva T; Siegal GP; Ponnazhagan S
Clin Cancer Res; 2008 Aug; 14(15):4961-70. PubMed ID: 18676771
[TBL] [Abstract][Full Text] [Related]
32. Umbilical cord-derived mesenchymal stem cells promote proliferation and migration in MCF-7 and MDA-MB-231 breast cancer cells through activation of the ERK pathway.
Li T; Zhang C; Ding Y; Zhai W; Liu K; Bu F; Tu T; Sun L; Zhu W; Zhou F; Qi W; Hu J; Chen H; Sun X
Oncol Rep; 2015 Sep; 34(3):1469-77. PubMed ID: 26151310
[TBL] [Abstract][Full Text] [Related]
33. Cdc42 negatively regulates intrinsic migration of highly aggressive breast cancer cells.
Zuo Y; Wu Y; Chakraborty C
J Cell Physiol; 2012 Apr; 227(4):1399-407. PubMed ID: 21618528
[TBL] [Abstract][Full Text] [Related]
34. [Transmembrane prostate androgen-induced protein 1 (PMEPA1) promotes the migration and maintains mesenchymal-like phenotype of breast cancer cells].
Zou Y; Zhang Y; Wang T; Wang S; Yang A; Jia L; Wang L
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2016 Feb; 32(2):158-62. PubMed ID: 26927372
[TBL] [Abstract][Full Text] [Related]
35. A comparative study of morphine stimulation and biphalin inhibition of human glioblastoma T98G cell proliferation in vitro.
Lazarczyk M; Matyja E; Lipkowski AW
Peptides; 2010 Aug; 31(8):1606-12. PubMed ID: 20580757
[TBL] [Abstract][Full Text] [Related]
36. DNALK2 inhibits the proliferation and invasiveness of breast cancer MDA-MB-231 cells through the Smad-dependent pathway.
Wang K; Sun X; Feng HL; Fei C; Zhang Y
Oncol Rep; 2017 Feb; 37(2):879-886. PubMed ID: 28075462
[TBL] [Abstract][Full Text] [Related]
37. Tryptophan hydroxylase 1 and 5-HT
Gautam J; Banskota S; Regmi SC; Ahn S; Jeon YH; Jeong H; Kim SJ; Nam TG; Jeong BS; Kim JA
Mol Cancer; 2016 Nov; 15(1):75. PubMed ID: 27871326
[TBL] [Abstract][Full Text] [Related]
38. Therapeutic effects of bach1 siRNA on human breast adenocarcinoma cell line.
Aletaha M; Mansoori B; Mohammadi A; Fazeli M; Baradaran B
Biomed Pharmacother; 2017 Apr; 88():34-42. PubMed ID: 28092843
[TBL] [Abstract][Full Text] [Related]
39. Aberrant expression of novel and previously described cell membrane markers in human breast cancer cell lines and tumors.
Huang H; Groth J; Sossey-Alaoui K; Hawthorn L; Beall S; Geradts J
Clin Cancer Res; 2005 Jun; 11(12):4357-64. PubMed ID: 15958618
[TBL] [Abstract][Full Text] [Related]
40. Reduction of breast cancer cell migration via up-regulation of TASK-3 two-pore domain K+ channel.
Lee GW; Park HS; Kim EJ; Cho YW; Kim GT; Mun YJ; Choi EJ; Lee JS; Han J; Kang D
Acta Physiol (Oxf); 2012 Apr; 204(4):513-24. PubMed ID: 21910834
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
